SCHEMBL30826071

SCHEMBL30826071

C/C(=N/NC(=O)c1ccc(C)c(C)c1)c1ccccn1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 10/20 0.72
▸ RAB9A P51151 9/20 0.72
▸ OPRK1 P41145 6/20 0.72
▸ KMT2A Q03164 5/20 0.72
▸ MEN1 O00255 3/20 0.72
▸ AGTR1 P30556 7/20 0.70
▸ L3MBTL1 Q9Y468 3/20 0.69
▸ GAA P10253 5/20 0.60
▸ MAPT P10636 3/20 0.60
▸ PKM P14618 1/20 0.58
▸ HSP90AA1 P07900 1/20 0.58
▸ POLB P06746 1/20 0.57
▸ TDP1 Q9NUW8 2/20 0.56
▸ MITF O75030 2/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ LMNA P02545 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ HTT P42858 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ KDM4E B2RXH2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30826078 1.00 NPC1 (0.72) NPC1RAB9AOPRK1KMT2AMEN1
SCHEMBL27178218 1.00 NPC1 (0.72) NPC1RAB9AOPRK1KMT2AMEN1
SCHEMBL27178211 1.00 NPC1 (0.72) NPC1RAB9AOPRK1KMT2AMEN1
SCHEMBL27178204 1.00 NPC1 (0.72) NPC1RAB9AOPRK1KMT2AMEN1
SCHEMBL30826076 0.85 NPC1 (0.62) NPC1RAB9AOPRK1KMT2AMEN1
SCHEMBL27178023 0.85 NPC1 (0.62) NPC1RAB9AOPRK1KMT2AMEN1
SCHEMBL27178031 0.85 NPC1 (0.62) NPC1RAB9AOPRK1KMT2AMEN1
SCHEMBL30826068 0.85 NPC1 (0.76) NPC1RAB9AOPRK1KMT2AMEN1
SCHEMBL27178190 0.85 NPC1 (0.76) NPC1RAB9AOPRK1KMT2AMEN1
SCHEMBL27178186 0.85 NPC1 (0.76) NPC1RAB9AOPRK1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240101510-A1 APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240101510-A1 APYRASE INHIBITORS APEH, DPEP1, PON1 NPC1 2564/4885RAB9A 1387/4885OPRK1 4716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback